• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

UBA52 抑制通过 EMC6 诱导自噬来抑制肝细胞癌的发生和发展。

Inhibition of UBA52 induces autophagy via EMC6 to suppress hepatocellular carcinoma tumorigenesis and progression.

机构信息

Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

Department of Pathology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

出版信息

J Cell Mol Med. 2024 Mar;28(6):e18164. doi: 10.1111/jcmm.18164.

DOI:10.1111/jcmm.18164
PMID:38445807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10915828/
Abstract

Ubiquitin A-52 residue ribosomal protein fusion product 1 (UBA52) has a role in the occurrence and development of tumours. However, the mechanism by which UBA52 regulates hepatocellular carcinoma (HCC) tumorigenesis and progression remains poorly understood. By using the Cell Counting Kit (CCK-8), colony formation, wound healing and Transwell assays, we assessed the effects of UBA52 knockdown and overexpression on the proliferation and migration of HCC cells in vitro. By establishing subcutaneous and metastatic tumour models in nude mice, we evaluated the effects of UBA52 on HCC cell proliferation and migration in vivo. Through bioinformatic analysis of data from the Gene Expression Profiling Interactive Analysis (GEPIA) and The Cancer Genome Atlas (TCGA) databases, we discovered that UBA52 is associated with autophagy. In addition, we discovered that HCC tissues with high UBA52 expression had a poor prognosis in patients. Moreover, knockdown of UBA52 reduced HCC cell growth and metastasis both in vitro and in vivo. Mechanistically, knockdown of UBA52 induced autophagy through EMC6 in HCC cells. These findings suggest that UBA52 promoted the proliferation and migration of HCC cells through autophagy regulation via EMC6 and imply that UBA52 may be a viable novel treatment target for HCC patients.

摘要

泛素 A-52 残基核糖体蛋白融合产物 1(UBA52)在肿瘤的发生和发展中具有作用。然而,UBA52 调节肝细胞癌(HCC)肿瘤发生和进展的机制仍知之甚少。通过使用细胞计数试剂盒(CCK-8)、集落形成、划痕愈合和 Transwell 分析,我们评估了 UBA52 敲低和过表达对 HCC 细胞体外增殖和迁移的影响。通过在裸鼠中建立皮下和转移肿瘤模型,我们评估了 UBA52 对 HCC 细胞体内增殖和迁移的影响。通过对基因表达谱交互式分析(GEPIA)和癌症基因组图谱(TCGA)数据库中数据的生物信息学分析,我们发现 UBA52 与自噬有关。此外,我们发现 UBA52 高表达的 HCC 组织患者预后不良。此外,UBA52 的敲低降低了 HCC 细胞在体外和体内的生长和转移。在机制上,UBA52 通过 HCC 细胞中的 EMC6 诱导自噬。这些发现表明,UBA52 通过 EMC6 调节自噬促进 HCC 细胞的增殖和迁移,并暗示 UBA52 可能是 HCC 患者的一种可行的新治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/545b/10915828/1cefa0b2f834/JCMM-28-e18164-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/545b/10915828/fe36450c7baf/JCMM-28-e18164-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/545b/10915828/e33b7e11d5a6/JCMM-28-e18164-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/545b/10915828/4f0b151bf0e9/JCMM-28-e18164-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/545b/10915828/5754eeb6dbf4/JCMM-28-e18164-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/545b/10915828/22ccc08befa2/JCMM-28-e18164-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/545b/10915828/1cefa0b2f834/JCMM-28-e18164-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/545b/10915828/fe36450c7baf/JCMM-28-e18164-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/545b/10915828/e33b7e11d5a6/JCMM-28-e18164-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/545b/10915828/4f0b151bf0e9/JCMM-28-e18164-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/545b/10915828/5754eeb6dbf4/JCMM-28-e18164-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/545b/10915828/22ccc08befa2/JCMM-28-e18164-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/545b/10915828/1cefa0b2f834/JCMM-28-e18164-g001.jpg

相似文献

1
Inhibition of UBA52 induces autophagy via EMC6 to suppress hepatocellular carcinoma tumorigenesis and progression.UBA52 抑制通过 EMC6 诱导自噬来抑制肝细胞癌的发生和发展。
J Cell Mol Med. 2024 Mar;28(6):e18164. doi: 10.1111/jcmm.18164.
2
SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.SOCS5 抑制通过 PI3K/Akt/mTOR 通路诱导自噬从而损害肝癌细胞的转移。
Cell Death Dis. 2019 Aug 13;10(8):612. doi: 10.1038/s41419-019-1856-y.
3
Aerobic glycolysis and tumor progression of hepatocellular carcinoma are mediated by ubiquitin of P53 K48-linked regulated by TRIM37.三甲基化 P53 K48 连接的泛素通过 TRIM37 调控有氧糖酵解和肝癌的肿瘤进展。
Exp Cell Res. 2022 Dec 15;421(2):113377. doi: 10.1016/j.yexcr.2022.113377. Epub 2022 Oct 14.
4
SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway.SLFN11 通过靶向 mTOR 通路抑制 RPS4X 抑制肝癌的发生和转移。
Theranostics. 2020 Mar 25;10(10):4627-4643. doi: 10.7150/thno.42869. eCollection 2020.
5
ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.ZEB1 通过转录激活 PFKM 增强了肝癌的瓦博格效应,促进了肿瘤的发生和转移。
Theranostics. 2021 Apr 3;11(12):5926-5938. doi: 10.7150/thno.56490. eCollection 2021.
6
Overexpression of ADAM9 decreases radiosensitivity of hepatocellular carcinoma cell by activating autophagy.ADAM9 的过表达通过激活自噬降低肝癌细胞的放射敏感性。
Bioengineered. 2021 Dec;12(1):5516-5528. doi: 10.1080/21655979.2021.1965694.
7
c-Src promotes the growth and tumorigenesis of hepatocellular carcinoma via the Hippo signaling pathway.c-Src 通过 Hippo 信号通路促进肝细胞癌的生长和肿瘤发生。
Life Sci. 2021 Jan 1;264:118711. doi: 10.1016/j.lfs.2020.118711. Epub 2020 Nov 10.
8
HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.HIF-1α 诱导的 m6A 阅读器 YTHDF1 通过促进 ATG2A 和 ATG14 的翻译,驱动肝癌的缺氧诱导自噬和恶性转化。
Signal Transduct Target Ther. 2021 Feb 23;6(1):76. doi: 10.1038/s41392-020-00453-8.
9
Liver-specific LINC01146, a promising prognostic indicator, inhibits the malignant phenotype of hepatocellular carcinoma cells both in vitro and in vivo.特异性 LINC01146,一种有前途的预后指标,在体外和体内均抑制肝癌细胞的恶性表型。
J Transl Med. 2022 Jan 31;20(1):57. doi: 10.1186/s12967-021-03225-2.
10
DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2.脱氧核糖核酸酶1样蛋白3通过抑制细胞周期蛋白依赖性激酶2(CDK2)介导的细胞周期进程来抑制肝细胞癌。
Cell Oncol (Dordr). 2022 Dec;45(6):1187-1202. doi: 10.1007/s13402-022-00709-1. Epub 2022 Nov 3.

引用本文的文献

1
SPDL1 overexpression was associated with poor prognosis and immune status in HCC through in vitro experiment and bioinformatics analysis.通过体外实验和生物信息学分析,SPDL1过表达与肝癌的不良预后和免疫状态相关。
Discov Oncol. 2025 Jul 11;16(1):1310. doi: 10.1007/s12672-025-03089-8.
2
Mechanisms and Factors Influencing Resorption of Herniated Part of Lumbar Disc Herniation: Comprehensive Review.腰椎间盘突出症突出部分吸收的机制及影响因素:综述
J Inflamm Res. 2025 Jun 30;18:8553-8562. doi: 10.2147/JIR.S525233. eCollection 2025.
3
Study on the molecular mechanism of UBA52 and BARD1 regulating hepatocellular carcinoma through the PI3 K/AKT signaling pathway.

本文引用的文献

1
ALDH2 as a potential stem cell-related biomarker in lung adenocarcinoma: Comprehensive multi-omics analysis.醛脱氢酶2作为肺腺癌中一种潜在的干细胞相关生物标志物:综合多组学分析
Comput Struct Biotechnol J. 2023 Feb 24;21:1921-1929. doi: 10.1016/j.csbj.2023.02.045. eCollection 2023.
2
Hepatocellular carcinoma and intrahepatic cholangiocarcinoma incidence between 2006 and 2015 in China: estimates based on data from 188 population-based cancer registries.2006年至2015年中国肝细胞癌和肝内胆管癌发病率:基于188个基于人群的癌症登记处数据的估计
Hepatobiliary Surg Nutr. 2023 Feb 28;12(1):45-55. doi: 10.21037/hbsn-21-75. Epub 2021 Jul 21.
3
UBA52和BARD1通过PI3K/AKT信号通路调控肝细胞癌的分子机制研究
Discov Oncol. 2025 May 21;16(1):840. doi: 10.1007/s12672-025-02600-5.
4
Changes in Protein Expression in Warmed Human Lens Epithelium Cells Using Shotgun Proteomics.运用鸟枪法蛋白质组学分析温育的人晶状体上皮细胞中的蛋白质表达变化
Medicina (Kaunas). 2025 Feb 7;61(2):286. doi: 10.3390/medicina61020286.
5
The perspective of ceRNA regulation of circadian rhythm on choroidal neovascularization.环状 RNA 调控生物钟对脉络膜新生血管的作用。
Sci Rep. 2024 Nov 9;14(1):27359. doi: 10.1038/s41598-024-78479-z.
6
Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy.靶向细胞死亡机制:自噬和铁死亡在肝细胞癌治疗中的潜力。
Front Immunol. 2024 Sep 9;15:1450487. doi: 10.3389/fimmu.2024.1450487. eCollection 2024.
Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches.
靶向和调控肝细胞癌中的自噬:重新探讨新治疗方法的分子相互作用和机制。
Cell Commun Signal. 2023 Feb 9;21(1):32. doi: 10.1186/s12964-023-01053-z.
4
UBA52 Attunes VDAC1-Mediated Mitochondrial Dysfunction and Dopaminergic Neuronal Death.泛素A52基因调节电压依赖性阴离子通道1介导的线粒体功能障碍和多巴胺能神经元死亡。
ACS Chem Neurosci. 2023 Mar 1;14(5):839-850. doi: 10.1021/acschemneuro.2c00579. Epub 2023 Feb 8.
5
Prospective role and immunotherapeutic targets of sideroflexin protein family in lung adenocarcinoma: evidence from bioinformatics validation.铁蛋白家族在肺腺癌中的预期作用和免疫治疗靶点:来自生物信息学验证的证据。
Funct Integr Genomics. 2022 Oct;22(5):1057-1072. doi: 10.1007/s10142-022-00883-3. Epub 2022 Jul 19.
6
The multifaceted role of autophagy in cancer.自噬在癌症中的多方面作用。
EMBO J. 2022 Jul 4;41(13):e110031. doi: 10.15252/embj.2021110031. Epub 2022 May 10.
7
Autophagy in age-related macular degeneration.年龄相关性黄斑变性中的自噬作用。
Autophagy. 2023 Feb;19(2):388-400. doi: 10.1080/15548627.2022.2069437. Epub 2022 May 1.
8
Autophagy-Related Signatures as Prognostic Indicators for Hepatocellular Carcinoma.自噬相关特征作为肝细胞癌的预后指标
Front Oncol. 2022 Mar 24;12:654449. doi: 10.3389/fonc.2022.654449. eCollection 2022.
9
The different autophagy degradation pathways and neurodegeneration.不同的自噬降解途径与神经退行性变。
Neuron. 2022 Mar 16;110(6):935-966. doi: 10.1016/j.neuron.2022.01.017. Epub 2022 Feb 7.
10
Loss of SPTBN1 Suppresses Autophagy Via SETD7-mediated YAP Methylation in Hepatocellular Carcinoma Initiation and Development.SPTBN1 缺失通过 SETD7 介导的 YAP 甲基化抑制肝癌起始和发展中的自噬。
Cell Mol Gastroenterol Hepatol. 2022;13(3):949-973.e7. doi: 10.1016/j.jcmgh.2021.10.012. Epub 2021 Nov 2.